GSM5917124 |
RNA_AML patient UPN02 at relapse (post transpantation) |
GSM5917125 |
RNA_AML patient UPN03 at diagnosis |
GSM5917126 |
RNA_AML patient UPN03 at relapse (post transpantation) |
GSM5917127 |
RNA_AML patient UPN04 at diagnosis |
GSM5917128 |
RNA_AML patient UPN04 at relapse (post transpantation) |
GSM5917129 |
RNA_AML patient UPN05 at diagnosis |
GSM5917130 |
RNA_AML patient UPN05 at relapse (post transpantation) |
GSM5917131 |
RNA_AML patient UPN06 at diagnosis |
GSM5917132 |
RNA_AML patient UPN06 at relapse (post chemotherapy) |
GSM5917133 |
RNA_AML patient UPN07 at diagnosis |
GSM5917134 |
RNA_AML patient UPN07 at relapse (post chemotherapy) |
GSM5917135 |
RNA_AML patient UPN08 at diagnosis |
GSM5917136 |
RNA_AML patient UPN08 at relapse (post chemotherapy) |
GSM5917137 |
RNA_AML patient UPN09 at diagnosis |
GSM5917138 |
RNA_AML patient UPN09 at relapse (post chemotherapy) |
GSM5917139 |
RNA_AML patient UPN010 at diagnosis |
GSM5917140 |
RNA_AML patient UPN010 at relapse (post chemotherapy) |
GSM5917141 |
RNA_Patient Derived Xenograft UPN01 at relapse + DMSO |
GSM5917142 |
RNA_Patient Derived Xenografts UPN01 at relapse + EPZ-6438 |
GSM5917143 |
RNA_Patient Derived Xenograft UPN02 at relapse + DMSO |
GSM5917144 |
RNA_Patient Derived Xenografts UPN02 at relapse + EPZ-6438 |
GSM5917145 |
RNA_Patient Derived Xenograft UPN03 at relapse + DMSO |
GSM5917146 |
RNA_Patient Derived Xenografts UPN03 at relapse + EPZ-6438 |
GSM5917147 |
RNA_Patient Derived Xenografts UPN01 at diagnosis, rep 1 |
GSM5917148 |
RNA_Patient Derived Xenografts UPN01 at relapse, rep 1 |
GSM5917149 |
RNA_Patient Derived Xenografts UPN01 at diagnosis, rep 2 |
GSM5917150 |
RNA_Patient Derived Xenografts UPN01 at relapse, rep 2 |
GSM5917151 |
RNA_Patient Derived Xenografts UPN01 at diagnosis, rep 3 |
GSM5917152 |
RNA_Patient Derived Xenografts UPN01 at relapse, rep 3 |